Point/Counterpoint. Low-dose radiation as a treatment for COVID-19 pneumonia: A threat or real opportunity?
- PMID: 32619276
- PMCID: PMC7362107
- DOI: 10.1002/mp.14367
Point/Counterpoint. Low-dose radiation as a treatment for COVID-19 pneumonia: A threat or real opportunity?
Conflict of interest statement
There is no conflict of interest to declare.
References
-
- Calabrese E, Dhawan G, Kapoor R, Kozumbo W. Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose. Hum Exp Toxicol. 2019;38:888–898. - PubMed
-
- Ghadimi‐Moghadam A, Haghani M, Bevelacqua JJ, Kaveh‐Ahangar A, Mortazavi SMJ, Mortazavi SAR. COVID‐19 tragic pandemic: concerns over unintentional "directed accelerated evolution" of novel coronavirus (SARS‐CoV‐2) and introducing a modified treatment method for ARDS. J Biomed Phys Eng. 2020;10:241–246. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
